Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Post by shawshank666on Aug 29, 2023 9:50am
106 Views
Post# 35609600

second quarter numbers

second quarter numbersExpect more of the same here. Little to no sales for the second quarter. The stock price ran up to 30 cents on the news of 2 sales in Germany. People thought this could be the beginning of an avalanche of sales but it is not happening. And so the stock price drifts lower.I even thought other hospitals would see the Germans buying the VMS and would think since the Germans are buying it must be good so we are going to buy. Unless there are potential sales happening we don't know about we could finish the year with just 2 sales of the VMS. Still better than last year where the revenue was $70,000 or the sale of one VMS unit but still not enough sales to justify a price of 30 cents or even 20 cents. The only person here that seems to get this here is this Graham poster. We need to have sales to justify the stock price. These conferences cost a lot of money to attend and if they don't result in any sales then it was a big waste of money. We are not going to go past 30 cents to 36 cents as people keep hoping if there aren't any more sales. This is a business. It will not exist much longer without first sales and then eventually profits. Do you understand this?
<< Previous
Bullboard Posts
Next >>